These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12092462)

  • 1. Cytokine and immunosuppressive therapies of type 1 diabetes mellitus.
    Gottlieb PA; Hayward AR
    Endocrinol Metab Clin North Am; 2002 Jun; 31(2):477-95. PubMed ID: 12092462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervention therapies for insulin-dependent diabetes.
    Muir A; Schatz DA; Pozzilli P; MacLaren NK
    Autoimmunity; 1993; 16(4):301-10. PubMed ID: 8025209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.
    Palmer JP
    J Clin Invest; 2001 Jul; 108(1):31-3. PubMed ID: 11435453
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunointervention in type 1 (insulin-dependent) diabetes mellitus.
    Keymeulen B; Somers G
    Acta Clin Belg; 1993; 48(2):86-95. PubMed ID: 8392249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and past prevention and intervention trials in type 1 diabetes.
    Staeva T
    Novartis Found Symp; 2008; 292():99-109; discussion 109-12, 122-9, 202-3. PubMed ID: 19203095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: experience in the NOD model.
    Mathieu C; Bouillon R; Rutgeerts O; Waer M
    Transplant Proc; 1995 Feb; 27(1):640-1. PubMed ID: 7879129
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.
    Azam A; Eisenbarth GS
    Expert Opin Biol Ther; 2004 Oct; 4(10):1569-75. PubMed ID: 15461568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreas islet xenografts but not allografts are resistant to autoimmune disease recurrence following islet transplantation.
    Thomas FT; Pittman K; Brezina P; Wu J; Mountz J; Contreras J; Thomas J
    Transplant Proc; 1997; 29(1-2):760-1. PubMed ID: 9123513
    [No Abstract]   [Full Text] [Related]  

  • 9. The murine autoimmune diabetes model: NOD and related strains.
    Kikutani H; Makino S
    Adv Immunol; 1992; 51():285-322. PubMed ID: 1323922
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
    Rabinovitch A; Suarez-Pinzon WL; Shapiro AM; Rajotte RV; Power R
    Diabetes; 2002 Mar; 51(3):638-45. PubMed ID: 11872661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies in immunotherapy of insulin-dependent diabetes mellitus.
    Bach JF
    Ann N Y Acad Sci; 1993 Nov; 696():364-76. PubMed ID: 8109843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of prevention and intervention trials for type 1 diabetes.
    Daaboul J; Schatz D
    Rev Endocr Metab Disord; 2003 Dec; 4(4):317-23. PubMed ID: 14618016
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin.
    Nicoletti F; Borghi MO; Meroni PL; Barcellini W; Fain C; Di Marco R; Menta R; Schorlemmer HU; Bruno G; Magro G
    Clin Exp Immunol; 1993 Feb; 91(2):232-6. PubMed ID: 8428390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune modulation therapy in type I diabetes mellitus].
    Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
    Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
    [No Abstract]   [Full Text] [Related]  

  • 15. Approaches to prevention and treatment of IDDM in animal models.
    Gottlieb PA; Rossini AA; Mordes JP
    Diabetes Care; 1988; 11 Suppl 1():29-36. PubMed ID: 3069388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.
    Simmons K; Michels AW
    Rheum Dis Clin North Am; 2014 Nov; 40(4):797-811. PubMed ID: 25437293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunointervention in newly diagnosed type 1 diabetes].
    Kaupper T; Walter M; Ziegler AG
    Dtsch Med Wochenschr; 2006 Dec; 131(49):2783-8. PubMed ID: 17136660
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental models suggest therapies for human diabetes.
    Smith R
    Lancet; 1996 Apr; 347(9009):1175. PubMed ID: 8609761
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention strategies for type 1 diabetes mellitus: current status and future directions.
    Winter WE; Schatz D
    BioDrugs; 2003; 17(1):39-64. PubMed ID: 12534319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of insulin-dependent diabetes.
    Bell DS; Acton RT
    Ala J Med Sci; 1985 Jul; 22(3):311-4. PubMed ID: 4025722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.